EDAP TMS (EDAP) announced the publication of the full results from the HIFI study in the prestigious, peer-reviewed journal, European Urology, which has the highest impact factor amongst scientific ...
12don MSN
EDAP reiterates 2026 core HIFU revenue of $50M-$54M as US procedures grow 53% year-over-year
Q1 2026 Management View “As announced this morning, we delivered a strong first quarter. We reported record first quarter total revenue for the company of $17.8 million, led by record first quarter ...
Non-inferior salvage treatment–free survival at 30 months favored HIFU (90%) versus salvage radical prostatectomy (86%), supporting HIFU as a curative-intent salvage alternative. Functional outcomes ...
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer. AUSTIN, ...
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue. Seventh Consecutive Quarter of Year-Over-Year HIFU Revenue Growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results